Skip to main content
Equibles

Connor, Clark & Lunn Investment Management Ltd.

Position in ASMB — Assembly Biosciences, Inc.

CIK 1596800 VANCOUVER, A1
Back to ASMB Full portfolio

Position in ASMB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$653,062
+$49,195 QoQ
Shares Held
23,765
+9.2% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 92 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ASMB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $648,992,404 across 104 Biotechnology names. ASMB ranks #71 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 135,236 $67,175,777
2 IONS
Ionis Pharmaceuticals Inc
 684,236 $54,253,072
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 625,569 $50,990,129
4 MIRM
Mirum Pharmaceuticals, Inc.
 420,063 $49,176,775
5 REGN
Regeneron Pharmaceuticals, Inc.
 42,465 $26,478,625
6 AXSM
Axsome Therapeutics, Inc.
 97,698 $23,913,539
7 INSM
INSMED Inc
 212,676 $22,675,515
8 VKTX
Viking Therapeutics, Inc.
 530,607 $20,698,979

All Filings in ASMB

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $653,062 23,765
2026-03-31 $603,867 21,761
2025-12-31 $707,476 20,802
2025-09-30 $285,593 11,156
2025-03-31 $97,339 10,182
2024-12-31 $170,629 10,813
2022-12-31 $85,010 65,393
2022-09-30 $212,793 129,752
2022-06-30 $300,121 142,915
2022-03-31 $339,796 164,950
2021-12-31 $396,603 170,216
2021-09-30 $544,324 156,415
2021-06-30 $588,506 151,677
2021-03-31 $638,226 138,745
2020-03-31 $237,235 15,997